GW Pharmaceuticals to Present at the Bank of America

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
145
GW Pharmaceuticals to Present at the Bank of America Merrill Lynch 2017 Health Care Conference on 17 May

LONDON, May 05, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced that Justin Gover, GW’s Chief Executive Officer, will present at the Bank of America Merrill Lynch 2017 Health Care Conference on Wednesday, May 17, 2017, at 10:00 a.m. (PDT) at the Encore at the Wynn Las Vegas, Las Vegas, Nev.  

A live audio webcast of the presentation will be available through GW’s corporate website in the investor relations section from the investor’s calendar of events page at www.gwpharm.com . A replay will be available soon after the live presentation.

About GW Pharmaceuticals plc

Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. GW is advancing an orphan drug program in the field of childhood epilepsy with a focus on Epidiolex ® (cannabidiol), which is in Phase 3 clinical development for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, Tuberous Sclerosis Complex and Infantile Spasms. GW commercialized the world’s first plant-derived cannabinoid prescription drug, Sativex ® (nabiximols), which is approved for the treatment of spasticity due to multiple sclerosis in 31 countries outside the United States. The Company has a deep pipeline of additional cannabinoid product candidates which includes compounds in Phase 1 and 2 trials for glioma, schizophrenia and epilepsy. For further information, please visit www.gwpharm.com .

Enquiries: GW Pharmaceuticals plc Stephen Schultz, VP Investor Relations (U.S.) 917 280 2424 / 401 500 6570

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 192

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 204

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 344

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 254

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 170

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 291

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 127

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 346

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 263

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 398

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading

Top 5 Most Recently Viewed Articles

Bitcoin's Consolidation Phase: A Bullish Sign for Altcoins

Updated Category News Views 168

Bitcoin's Recent Market Developments Bitcoin is currently seeing a phase of consolidation, with its price stabilizing approximately 5% above previous all-time highs. This behavior suggests a strong underlying structure in the market, according to various analysts. Recently, Bitcoin has displayed notable resilience despite potential volatility in price patterns. This...

Continue Reading
Transform Your Investment: Insights on Imperial Oil Growth

Updated Category News Views 101

Imperial Oil's Impressive Growth Over Five Years Over the last five years, Imperial Oil (AMEX: IMO) has demonstrated remarkable performance, surpassing the overall market by an impressive 7.98% each year. This achievement translates to an average annual return of 20.59%, making it a compelling option for investors seeking to enhance their portfolios. Visualizing Your...

Continue Reading
Investing Wisely: What You Need to Know About PubMatic Lawsuit

Updated Category News Views 162

Understanding the Class Action Lawsuit Against PubMatic PubMatic, Inc. has recently come under scrutiny as a class action lawsuit has been filed, bringing investor concerns to the forefront. The legal action involves allegations that PubMatic and some of its senior executives may have engaged in fraudulent activities or violated business regulations, creating a...

Continue Reading
Projected Growth of the Global Rocket and Missile Industry

Updated Category News Views 57

Projected Growth of the Global Rocket and Missile Industry The global rocket and missile market is on a trajectory to reach an impressive USD 85.22 billion by 2029, marking a significant increase from USD 62.50 billion in 2024. This growth showcases the expanding landscape of the defense sector, with a compound annual growth rate (CAGR) of 6.4%. Various driving factors...

Continue Reading
Grossman Law Offices Secures Landmark Truck Accident Settlement

Updated Category News Views 232

Groundbreaking Truck Accident Settlement By Grossman Law Offices In an impressive legal feat, Grossman Law Offices has achieved a remarkable settlement in a case involving catastrophic injuries from a truck accident. This Dallas-based firm has been recognized for securing what is now considered the largest publicly reported truck accident settlement in Texas since 2021....

Continue Reading